Literature DB >> 32875382

Association of Sexualized Drug Use Patterns with HIV/STI Transmission Risk in an Internet Sample of Men Who Have Sex with Men from Seven European Countries.

Juan-Miguel Guerras1, Juan Hoyos Miller2,3, Cristina Agustí4,5, Sophocles Chanos6, François Pichon7, Matthias Kuske8, Bojan Cigan9, Ricardo Fuertes10, Roxana Stefanescu11, Lieselot Ooms12, Jordi Casabona4,5, Luis de la Fuente1,4, María-José Belza4,13.   

Abstract

We estimated the prevalence of overall sexualized drug use (SDU) and of chemsex in particular, assessed patterns of drug use, and identified subpopulations of men who have sex with men (MSM) where SDU and chemsex are more frequent. Using data from an online survey of 9407 MSM recruited during 2016 in 7 European countries, we calculated the proportion of participants who reported SDU and chemsex (mephedrone, methamphetamine, and/or GHB/GBL) in the last 12 months. We grouped the different drug-use combinations in patterns and described sexual risk behaviors, sexually transmitted infections (STI), and HIV seropositivity for each one of them. Factors associated with SDU and chemsex were assessed with two logistic regression models. SDU was reported by 17.7% and chemsex by 5.2%. Risk indicators increased through the different SDU patterns but were higher within those including chemsex drugs. In the multivariate analysis, chemsex was independently associated with living in Slovenia. Both SDU and chemsex were independently associated with living in Spain; being < 50 years old; living in cities of > 500,000 inhabitants; being open about their sex life; reporting transactional sex; condomless anal intercourse; having received an STI diagnosis and with being HIV positive or having been tested ≤ 12 months ago. Magnitude of associations was higher in the chemsex model. One in five participants reported SDU, but prevalence of chemsex was notably lower. However, the risk profiles and higher prevalence of HIV/STIs among those involved in chemsex suggest the existence of a subpopulation of MSM that could be playing a relevant role in the HIV and STI epidemics, especially in very large cities of some countries.

Entities:  

Keywords:  Chemsex; HIV; Men who have sex with men; Sexual orientation; Sexualized drug use

Year:  2020        PMID: 32875382     DOI: 10.1007/s10508-020-01801-z

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  59 in total

1.  Assessment of an outreach street-based HIV rapid testing programme as a strategy to promote early diagnosis: a comparison with two surveillance systems in Spain, 2008-2011.

Authors:  M J Belza; J Hoyos; S Fernández-Balbuena; A Diaz; M J Bravo; L de la Fuente
Journal:  Euro Surveill       Date:  2015-04-09

Review 2.  Substance use among men who have sex with men: patterns, motivations, impacts and intervention development need.

Authors:  Adam Bourne; Peter Weatherburn
Journal:  Sex Transm Infect       Date:  2017-04-11       Impact factor: 3.519

Review 3.  Does being drunk or high cause HIV sexual risk behavior? A systematic review of drug administration studies.

Authors:  Meredith S Berry; Matthew W Johnson
Journal:  Pharmacol Biochem Behav       Date:  2017-08-24       Impact factor: 3.533

4.  Substance use and sexual risk behavior in HIV-positive men who have sex with men: an episode-level analysis.

Authors:  Melissa R Boone; Stephanie H Cook; Patrick Wilson
Journal:  AIDS Behav       Date:  2013-06

5.  Increasing use of 'party drugs' in people living with HIV on antiretrovirals: a concern for patient safety.

Authors:  Margherita Bracchi; David Stuart; Richard Castles; Saye Khoo; David Back; Marta Boffito
Journal:  AIDS       Date:  2015-08-24       Impact factor: 4.177

6.  Stimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapy.

Authors:  Adam W Carrico; Steven Shoptaw; Christopher Cox; Ronald Stall; Xiuhong Li; David G Ostrow; David Vlahov; Michael W Plankey
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-15       Impact factor: 3.731

7.  Drug use, high-risk sex behaviors, and increased risk for recent HIV infection among men who have sex with men in Chicago and Los Angeles.

Authors:  James W Carey; Roberto Mejia; Trista Bingham; Carol Ciesielski; Deborah Gelaude; Jeffrey H Herbst; Michele Sinunu; Ekow Sey; Nikhil Prachand; Richard A Jenkins; Ron Stall
Journal:  AIDS Behav       Date:  2008-05-23

Review 8.  Critical Review: When the Party is Over: A Systematic Review of Behavioral Interventions for Substance-Using Men Who Have Sex with Men.

Authors:  Adam W Carrico; Roland Zepf; Steven Meanley; Abigail Batchelder; Ronald Stall
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

9.  Integrating routine HIV testing into a public health STD clinic.

Authors:  Doug Campos-Outcalt; Tom Mickey; Jonathan Weisbuch; Robert Jones
Journal:  Public Health Rep       Date:  2006 Mar-Apr       Impact factor: 2.792

10.  Sexual risk and HIV acquisition among men who have sex with men travelers to Key West, Florida: a mathematical modeling analysis.

Authors:  Eric G Benotsch; John J Mikytuck; Kathleen Ragsdale; Steven D Pinkerton
Journal:  AIDS Patient Care STDS       Date:  2006-08       Impact factor: 5.944

View more
  8 in total

Review 1.  Running with Scissors: a Systematic Review of Substance Use and the Pre-exposure Prophylaxis Care Continuum Among Sexual Minority Men.

Authors:  Michael Viamonte; Delaram Ghanooni; John M Reynolds; Christian Grov; Adam W Carrico
Journal:  Curr HIV/AIDS Rep       Date:  2022-06-14       Impact factor: 5.495

Review 2.  Collateral Damage: A Narrative Review on Epidemics of Substance Use Disorders and Their Relationships to Sexually Transmitted Infections in the United States.

Authors:  Steffanie Ann Strathdee; Claire C Bristow; Tommi Gaines; Steven Shoptaw
Journal:  Sex Transm Dis       Date:  2021-07-01       Impact factor: 3.868

3.  Sexualized drug injection among men who have sex with men in Madrid and Barcelona as the first episode of drug injecting.

Authors:  Juan-Miguel Guerras; Patricia García de Olalla; María José Belza; Luis de la Fuente; David Palma; Jorge Del Romero; Jorge-Néstor García-Pérez; Juan Hoyos
Journal:  Harm Reduct J       Date:  2021-08-06

4.  Impact of COVID-19 Pandemic on Men Who Have Sex With Men That Practice Chemsex in France: Results From the National ERAS Web Survey.

Authors:  Perrine Roux; Cécile Donadille; Gabriel Girard; Bruno Spire; Christel Protière; Annie Velter
Journal:  Am J Mens Health       Date:  2022 Jan-Feb

5.  Increasing emergency department admissions for chemsex-related intoxications in Barcelona, Spain, among people living with HIV: an observational study from 2018 to 2020.

Authors:  Gabriel Vallecillo; Alejandra Losada; Alexy Inciarte; Chen Jiwei; Albert Monterde; Emilio Salgado; Adriana Laura Doi; Esther Monclus; Rafael Perelló
Journal:  BMC Public Health       Date:  2022-02-18       Impact factor: 3.295

6.  Chems4EU: chemsex use and its impacts across four European countries in HIV-positive men who have sex with men attending HIV services.

Authors:  Gary G Whitlock; Konstantinos Protopapas; Jose I Bernardino; Arkaitz Imaz; Adrian Curran; Christof Stingone; Sivapatham Shivasankar; Sarah Edwards; Sophie Herbert; Konstantinos Thomas; Rafael Mican; Paula Prieto; Jorge Nestor Garcia; Massimo Andreoni; Samantha Hill; Hajra Okhai; David Stuart; Adam Bourne; Katie Conway
Journal:  HIV Med       Date:  2021-08-25       Impact factor: 3.094

7.  Prediction Model for the Risk of HIV Infection among MSM in China: Validation and Stability.

Authors:  Yinqiao Dong; Shangbin Liu; Danni Xia; Chen Xu; Xiaoyue Yu; Hui Chen; Rongxi Wang; Yujie Liu; Jingwen Dong; Fan Hu; Yong Cai; Ying Wang
Journal:  Int J Environ Res Public Health       Date:  2022-01-17       Impact factor: 3.390

Review 8.  Mental Health Symptoms Associated with Sexualized Drug Use (Chemsex) among Men Who Have Sex with Men: A Systematic Review.

Authors:  Daniel Íncera-Fernández; Manuel Gámez-Guadix; Santiago Moreno-Guillén
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.